Bristol-Myers Squibb Company (0R1F)
LSE
Closed
Oct 8, 2026
Day's Range
58.5452 wk Range
42.54Overview - 0R1F - Bristol-Myers Squibb Company
Key Statistics
Valuation
Enterprise Value
149.31B
P/E (Trailing)
‪16.22‬
PEG Ratio
‪0.10‬
Price / Sales (TTM)
‪2.86‬
Price / Book
‪3.93‬
EV / EBITDA
‪7.98‬
Profitability
Gross Margin
‪71.27%‬
Profit Margin
‪17.62%‬
Operating Margin
‪19.25%‬
Return on Assets
‪5.61%‬
Return on Equity
‪24.66%‬
Ownership
Shares Outstanding
2.04B
Float
2.08B
Held by Insiders
‪0.07%‬
Held by Institutions
‪78.20%‬
Price stats
Beta
‪0.34‬
50-Day Avg
‪64.51‬
200-Day Avg
‪59.62‬
Dividends
Payout Ratio
‪59.84%‬
Frequency
Quarterly
Market Cap - 0R1F - Bristol-Myers Squibb Company
Peers - 0R1F - Bristol-Myers Squibb Company
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on LSE.
- 0R1FLSEBristol-Myers Squibb Company128.23BMarket Cap+26.81%52-week change16.22P/E (Trailing)‪17.62%‬Profit Margin
- AZNLSEAstraZeneca PLC18.97TMarket Cap+2.93%52-week change25.26P/E (Trailing)‪17.02%‬Profit Margin
- GSKLSEGSK plc7.41TMarket Cap+21.34%52-week change16.10P/E (Trailing)‪14.52%‬Profit Margin
- SANLSESantander UK Plc Preferred Stock 10.375% Perpetual4.72TMarket Cap+98.91%52-week change0.38P/E (Trailing)‪19.73%‬Profit Margin
- 0QIULSENovo Nordisk A/S1.06TMarket Cap-37.73%52-week change17.11P/E (Trailing)‪33.39%‬Profit Margin
- 0Q1GLSEEli Lilly and Company984.08BMarket Cap+26.67%52-week change1.49P/E (Trailing)‪33.52%‬Profit Margin
- 0QCVLSEAbbVie Inc.476.72BMarket Cap+16.79%52-week change54.53P/E (Trailing)‪15.50%‬Profit Margin
Profile Summary - 0R1F - Bristol-Myers Squibb Company
About
Bristol-Myers Squibb Company is a global biopharmaceutical company that discovers, develops, manufactures, and commercializes medicines for serious diseases. Bristol-Myers Squibb Company focuses on major therapeutic areas including oncology, hematology, immunology, cardiovascular disease, and neuroscience, serving…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
